From the Food and Drug Administration.
D000293:Adolescent; D000328:Adult; D015374:Biosensing Techniques; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation*; D002648:Child; D002986:Clinical Trials as Topic / Q000592:standards*; D004338:Drug Combinations; D004339:Drug Compounding / Q000592:standards; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D010594:Pharmacies / Q000331:legislation & jurisprudence / Q000592:standards*; D017698:Postmenopause; D015871:Scientific Misconduct; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); C466383:Prempro; D017258:Medroxyprogesterone Acetate